Corrigendum [0.03%]
勘误表
Published Erratum
Expert opinion on therapeutic patents. 2018 Aug;28(8):653. DOI:10.1080/13543776.2018.1502972 2018
New strategies for patenting biological medicines used in rheumatoid arthritis treatment [0.03%]
类风湿性关节炎治疗中生物药物专利的新策略
Rodrigo Ayres de Oliveira,Iolanda M Fierro
Rodrigo Ayres de Oliveira
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an inflammatory process, with a global prevalence ranging from 0.3% to 1%. The overall cost of RA drugs is estimated in $20 billion ...
Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type-2 inflammation: a patent evaluation (WO2017/058370) [0.03%]
用于调节肥大细胞造血和2型炎症的碳酸酐酶专利分析(WO2017/058370)
Jean-Yves Winum
Jean-Yves Winum
Activity modulators of carbonic anhydrases hold great potential for several therapeutic applications against ophthalmologic and neurological disease, cancer, and infectious diseases. The involvement of carbonic anhydrase in the regulation o...
Claudiu T Supuran,Clemente Capasso
Claudiu T Supuran
Introduction: The hydration/dehydration of CO2 catalyzed by carbonic anhydrases (CAs, EC 4.2.1.1) is a crucial physiological reaction for the survival of all living organisms because it is connected with numerous biosynth...
Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist: a patent evaluation of CA2958110 and IN6616DEN2012 [0.03%]
碳酐酶抑制剂与醛固酮拮抗剂联合治疗睡眠呼吸暂停：CA2958110和IN6616DEN2012专利分析
Andrea Angeli,Claudiu T Supuran
Andrea Angeli
Sleep apnoea syndrome (SAS), is a sleep disorder and characterized by very shallow breath or repetitive cessation of breathing during sleep (sleep apnoea). At present, no pharmacological agents have proved to be successful against SAS, and ...
HIV cure: global overview of bNAbs' patents and related scientific publications [0.03%]
HIV治愈：广义bNAbs专利及相关科学文献的全球概览
Cristina Possas,Adelaide Maria de Souza Antunes,Flavia Maria Lins Mendes et al.
Cristina Possas et al.
Introduction: This article provides a global overview of patent deposits for broadly neutralizing antibodies (bNAbs), which have emerged as a key strategy for HIV cure and future HIV vaccines. Scientific and technological...
Emerging patents in the therapeutic areas of glioma and glioblastoma [0.03%]
少突胶质瘤和间变性少突胶质瘤的新兴专利疗法领域
Matthew Harris,Fredrik Svensson,Liliya Kopanitsa et al.
Matthew Harris et al.
Introduction: Glioblastoma multiforme (GBM) is the most common and aggressive malignant glioma, with patients having a median survival of just over one year. Current chemotherapies, with surgery and radiotherapy, provide ...
İlhami Gulçin,Parham Taslimi
İlhami Gulçin
Introduction: Sulfonamide compounds are significant class of synthetic bacteriostatic antibiotics still which used today for the therapy of bacterial infections and those caused by other microorganisms. They are also know...
Kenya Felicíssimo,Cristina M Quintella,Juliana Stuginski et al.
Kenya Felicíssimo et al.
Introduction: Bruxism is among the most chronic dental problems worldwide, and its perception may increase indicatively the condition of people's health, avoiding future health problems. Technologic solutions have improve...
Eva Ogorevc,Eva Shannon Schiffrer,Izidor Sosič et al.
Eva Ogorevc et al.
Introduction: The ubiquitin-proteasome system is responsible for maintaining protein homeostasis and regulating a variety of cellular processes. The constitutive proteasome is expressed in all cells while the immunoprotea...